Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-25-008132
Filing Date
2025-03-14
Accepted
2025-03-14 17:07:15
Documents
2
Period of Report
2025-03-06

Document Format Files

Seq Description Document Type Size
1 form3-03142025_090311.html 3  
1 form3-03142025_090311.xml 3 1659
2 ex24-03142025_090314.htm EX-24 4751
  Complete submission text file 0001415889-25-008132.txt   7913
Mailing Address 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753
Business Address 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753 650-249-9090
Natera, Inc. (Issuer) CIK: 0001604821 (see all company filings)

EIN.: 010894487 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)

Mailing Address C/O LEAP THERAPEUTICS, INC. 47 THORNDIKE STREET, SUITE B1-1 CAMBRIDGE MA 02141
Business Address
Bertagnolli Monica (Reporting) CIK: 0001761030 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37478 | Film No.: 25741208